Barbara Allegrezza, et al. v. Monsanto Co.

CONCLUDED

Trial
09/13/23 – 09/28/23

Summary

In this trial, Mark McCostlin developed non-Hodgkin lymphoma, which his representatives claim was due to his use of Monsanto's Roundup herbicide. Plaintiffs allege that Monsanto was aware of Roundup's carcinogenic risks yet hid them for financial gain.

Defendant Monsanto claims that Roundup is safe and that studies showing an increase in cancer from glyphosate, an active ingredient in the herbicide, rely upon flawed science.

Outcome

Directed verdict for the defense

Sessions

SEP
19
AM Session
Judge Motion Ruling
2 Chapters
SEP
28

Recording Disclaimer: This proceeding was recorded in full.

AudioCaseFiles

Exclusive audio opinions to enhance your law school experience

AudioCaseFiles

Essentials

The most important and informative moments of each trial

Essentials

Training Libraries

Trial Advocacy, Rules of Evidence and Appellate Advocacy

Training

  • Follow Us